Mitral Atresia
Symptoms, Doctors, Treatments, Advances & More

Mitral Atresia Overview

Save information for later
Sign Up

Learn About Mitral Atresia

What is the definition of Mitral Atresia?
Mitral valve atresia is a rare congenital (present at birth) defect of the heart’s mitral valve. The mitral valve connects the heart’s left atrium (upper chamber) and left ventricle (lower chamber). In mitral valve atresia blood from the left atrium does not flow to the left ventricle, causing the left ventricle to become underdeveloped, while the body's blood is not properly oxygenated. Mitral valve atresia is often associated with other congenital heart defects, such as transposition of the great arteries, patent ductus arteriosus, and coarctation of the aorta, among others.
What are the symptoms of Mitral Atresia?
Symptoms of mitral valve atresia depend on its severity and any associated congenital heart defects and may include difficulty breathing; rapid breathing; bluish or gray skin, lips, or nails (cyanosis); pale, cool, or clammy skin; poor peripheral pulses; rapid heart rate; failure to thrive; and congestive heart failure.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Mitral Atresia?
Treatment for mitral valve atresia may include oxygen, mechanical ventilation, diuretics, vasopressors, antibiotics, shunts, and staged corrective surgeries.
Who are the top Mitral Atresia Local Doctors?
Advanced in Mitral Atresia
Advanced in Mitral Atresia
Referral may be required

Duke Cardiology Arringdon

5601 Arringdon Park Dr, 
Morrisville, NC 
919-997-3100
Languages Spoken:
English, Hindi, Kannada
See accepted insurances
Accepting New Patients
Offers Telehealth

Bharathi Upadhya is a Cardiologist practicing medicine in Morrisville, North Carolina. Dr. Upadhya is rated as an Advanced provider by MediFind in the treatment of Mitral Atresia. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Hypertensive Heart Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pacemaker Implantation, and Atherectomy. Dr. Upadhya is board certified in American Board Of Internal Med, Cardiovascular Disease and American Board Of Internal Med, Adult Congenital Heart Disease. Dr. Upadhya is currently accepting new patients.

Advanced in Mitral Atresia
Dr. James P. Strainic
Pediatric Cardiology
Advanced in Mitral Atresia
Dr. James P. Strainic
Pediatric Cardiology
Referral may be required

University Hospitals

11100 Euclid Ave, 
Cleveland,, OH 
216-844-3528
Languages Spoken:
English
See accepted insurances
Accepting New Patients

James Strainic is a Pediatric Cardiologist practicing medicine in Cleveland,, Ohio. Dr. Strainic is rated as an Advanced provider by MediFind in the treatment of Mitral Atresia. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Pulmonary Atresia, Pulmonary Atresia with Intact Ventricular Septum, Ventricular Septal Defects, and Bicuspid Aortic Valve. Dr. Strainic is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Mitral Atresia
Dr. Michael J. Farias
Pediatric Cardiology
Advanced in Mitral Atresia
Dr. Michael J. Farias
Pediatric Cardiology
Referral may be required

Department Of Cardiology

300 Longwood Ave, 
Boston, MA 
617-355-2079
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Farias is a Pediatric Cardiologist practicing medicine in Boston, Massachusetts. Dr. Farias is rated as an Advanced provider by MediFind in the treatment of Mitral Atresia. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Patent Ductus Arteriosus, Hypoplastic Left Heart Syndrome (HLHS), Pulmonary Vein Stenosis, Spinal Fusion, and Osteotomy. Dr. Farias is currently accepting new patients.

View All Doctors
What are the latest Mitral Atresia Clinical Trials?
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.
Who is this study for: Patients with Hypoplastic Left Heart Syndrome, Congential Heart Defects
Enrollment Status: Recruiting
Publish Date: June 27, 2025
Intervention Type: Combination product
Study Drug: Tissue Engineered Vascular Grafts
Study Phase: Phase 2

Summary: A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials